To Be or Not IIb: A Multi-Step Process for Epstein-Barr Virus Latency Establishment and Consequences for B Cell Tumorigenesis

Mitogen-Induced B-Cell Proliferation Activates Chk2-Dependent G1/S Cell Cycle Arrest

(2014) Pavel A. Nikitin et al.   PLoS One

Gammaherpesviruses and Lymphoproliferative Disorders

(2013) Ethel Cesarman   Annual Review of Pathology-Mechanisms of Disease

EBV genome carrying B lymphocytes that express the nuclear protein EBNA-2 but not LMP-1

(2013) Eva Klein et al.   OncoImmunology

Analysis of Epstein-Barr Virus-Regulated Host Gene Expression Changes through Primary B-Cell Outgrowth Reveals Delayed Kinetics of Latent Membrane Protein 1-Mediated NF- B Activation

(2012) A. M. Price et al.   JOURNAL OF VIROLOGY

An ATM/Chk2-Mediated DNA Damage-Responsive Signaling Pathway Suppresses Epstein-Barr Virus Transformation of Primary Human B Cells

(2010) Pavel A. Nikitin et al.   Cell Host & Microbe

A New Model of Epstein-Barr Virus Infection Reveals an Important Role for Early Lytic Viral Protein Expression in the Development of Lymphomas

(2010) S.-D. Ma et al.   JOURNAL OF VIROLOGY

Cyclical Expression of EBV Latent Membrane Protein 1 in EBV-Transformed B Cells Underpins Heterogeneity of Epitope Presentation and CD8+ T Cell Recognition

(2009) J. M. Brooks et al.   JOURNAL OF IMMUNOLOGY

Early Events Associated with Infection of Epstein-Barr Virus Infection of Primary B-Cells

(2009) Sabyasachi Halder et al.   PLoS One

IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter

(2009) L. L. Kis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp/BHRF1 Link

(2009) Gemma L. Kelly et al.   PLoS Pathogens